Literature DB >> 15081079

Do cultures contribute to optimisation of antibiotic therapy in the intensive care unit?

C A M Schurink1, M Hoitsma, M Rozenberg-Arska, J C A Joore, I M Hoepelman, M J M Bonten.   

Abstract

Obtaining diagnostic microbiological cultures before initiating empirical antimicrobial therapy is part of the diagnostic work-up of intensive care patients with a clinical suspicion of infection. However, it is unknown to what extent these cultures provide a microbiological cause of infection and to what extent antimicrobial therapy is influenced. During a 6-month period, all episodes of suspected clinical infection were analysed and categorised as non-microbiologically proven infection (non-MPI) or MPI. Effects of culture results on antibiotic therapy were analysed for episodes of respiratory tract infection. Invasive diagnostic techniques were not routinely used for diagnosis of respiratory tract infections. Among 212 patients admitted, 147 episodes of clinical suspicion of infection were recorded (104 for respiratory tract infection) and 1147 microbiological cultures were obtained (0.64 culture per patient day). Antibiotics were administered on 1111 (62%) of 1803 patients days. Of the respiratory tract infections, 571 cultures resulted in 49 (47%) MPI. Cover with empirical antibiotics was inappropriate in 7 of 104 cases (8%) of respiratory infections. In 12 cases (11.5%) empirical therapy could have been changed based on culture results. Negative cultures were never followed by cessation of therapy, but the duration of treatment was significantly shorter for non-MPI. Forty-seven percent of respiratory tract infections were microbiologically confirmed and, based on culture results, empirical antimicrobial therapy could have been influenced in 11.5% of cases of respiratory tract infections. These findings provide aspects to evaluate and improve the diagnostic work-up of infections in the ICU.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15081079     DOI: 10.1016/j.ijantimicag.2003.08.013

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  5 in total

1.  Antibiotic Use and Presumptive Pathogens in the Veterans Affairs Healthcare System.

Authors:  Christine Tedijanto; McKenna Nevers; Matthew H Samore; Marc Lipsitch
Journal:  Clin Infect Dis       Date:  2022-01-07       Impact factor: 9.079

2.  Feasibility of De-Escalation Implementation for Positive Blood Cultures in Patients With Sepsis: A Prospective Cohort Study.

Authors:  José Victor de Miranda Pedroso; Fabiane Raquel Motter; Sonia Tiemi Koba; Mayara Costa Camargo; Maria Inês de Toledo; Fernando de Sá Del Fiol; Marcus Tolentino Silva; Luciane Cruz Lopes
Journal:  Front Pharmacol       Date:  2021-02-12       Impact factor: 5.810

3.  Intensivists' beliefs about rapid multiplex molecular diagnostic testing and its potential role in improving prescribing decisions and antimicrobial stewardship: a qualitative study.

Authors:  Alyssa M Pandolfo; Robert Horne; Yogini Jani; Tom W Reader; Natalie Bidad; David Brealey; Virve I Enne; David M Livermore; Vanya Gant; Stephen J Brett
Journal:  Antimicrob Resist Infect Control       Date:  2021-06-29       Impact factor: 4.887

4.  Antibiotic prescriptions in critically-ill patients: a latin american experience.

Authors:  D Curcio
Journal:  Ann Med Health Sci Res       Date:  2013-04

Review 5.  Knowledge, attitude, perception and practice regarding antimicrobial use in upper respiratory tract infections in Qatar: a systematic review.

Authors:  F Shaikhan; S Rawaf; A Majeed; S Hassounah
Journal:  JRSM Open       Date:  2018-09-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.